Abstract. Over a decade,
Argon laser treatment of the trabecular meshwork was described in the United States by Worthen and Wickham"' in 1973 . The modified technique later described by Wise and Witter17' in 1979 gained acceptance and popularity within a short time and now plays an important role in the treatment of advanced open-angle glaucoma. Yet, despite widespread use, many basic questions concerning the treatment parameters, mechanism of action, and efricacy of the treatment remain unanswered. 'l-his will review the large body of literature concerning argon laser trabeculoplasty and will also attempt to of'fer a reasonable treatment approach to the patient who may benefit from argon laser trabeculoplasty (ALT).
I. Historical Perspective
Laser technology first became available in the early 1960s. Its application to the anterior chamber angle structures solely for the purpose of reducing intraocular pressure (IOP) was not reported in the American literature until 1973.17' In that year, Krasnov described a "micropuncture" technique utilizing a Q-switched ruby laser in ten chronic 407 open-angle glaucoma patients in Russia."' A temporary reduction of IOP in all subjects, accompanied by improved outflow facilities was noted in this early report."g This technique, termed laser trabeculotomy, attempted to provide a direct aqueous pathway into Schlemm's canal.
Worthen and Wickham described the cellular and histopathological changes associated with argon laser applications of varying intensity in monkeys. I"? The following year, their human clinical studies, which were the first conducted and published in the United States, drew attention to the potential use of laser treatment in open-angle glaucoma. Although the power levels and duration settings were significantly higher than those employed in present-day techniques," ' an average IOP reduction of 9.6 % 8.9 mm Hg in 20 patients three weeks after the treatment was noted. Four patients, who were followed up for one year, demonstrated an average decrease in IOP of 11.3 mm Hg. EXtended follow-up of Worthen and Wickham's patients suggested that conventional surgery could be delayed for three months to three years following laser, which was a desirable treatment outcome in REISS ET AL itself. The results prompted these investigators to propose that "argon laser trabeculotomy" should be tried before resorting to conventional glaucoma surgery. I59 Ticho and Zauberman,'3g using the argon laser, noted improvement in the outflow facilities of glaucomatous eyes after laser treatment. Other investigators441'"J reported success with argon laser treatment.
However, enthusiasm for these techniques was dampened by the adverse effects (most significantly, increased IOP) of laser treatment to the trabecular meshwork reported in animals 33,17? Interest in argon laser treatment in glaucoma management increased after a report by Wise and Witter in 1979 .17' These investigators used less energy and reported moderate pressure reduction and few complications. One-hundred laser burns at a power level ranging from 1000 to 1500 mW were placed over 360" of trabecular meshwork. The burns, which were 50 F in size and 0.1 set in duration, produced an average pressure reduction of 10.29 mm Hg at three months in 41 patients with primary open angle glaucoma. They postulated that localized burns in the trabecular meshwork caused shrinkage of collagen in the tissue, resulting in a pulling or tightening of the adjacent tissues. This was thought to result in widening of the trabecular pores and a reduction in outflow resistance. Published reports in 1981 of this technique, now known as ALT, by Schwartz et al,"" Wilensky and Jampol,'6S Sutton et a1,13' and Pohjanpeltox" confirmed the initial success reported by Wise."'
II. Theories Regarding the Mechanism of Action of Argon Laser Trabeculoplasty
The effects of ALT on aqueous outflow as well as inflow have been studied. Many of the earliest investigators demonstrated that improvement of tonographic outflow facility occurred following laser treatment to the angle structures.6"'"g Clinical studies that utilized the Wise technique (ALT) also revealed increased outflow facility.2'v"6,' '*,'96*'63,'74 Utilizing fluorophotometry, Brubaker and Liesegang found that aqueous flow, cornea1 permeability to fluorescein, and the blood-aqueous exchange coefficient did not differ significantly in 17 treated eyes when compared to controls.'3 Other investigators noted a temporary breakdown in the blood-aqueous barrier following laser trabeculoplasty; however, this finding is unlikely to have any longterm significance. *' Thus, it was established that an increase in the facility of aqueous outflow was the most significant determinant which modified intraocular pressure following ALT.
The question remains -by what mechanism is aqueous outflow improved? Some of the various theories proposed have been discussed in detail by Van Buskirk.14" Initially, Wise and Witter17' proposed that ALT worked by reversing a pathological laxity of the trabecular tissues, which resulted in a collapse of the meshwork, subsequently diminishing aqueous outflow facility. One could envision microscars causing tissue retraction around the entire trabecular circumference, which would literally pull the meshwork open between the scars (Fig. 1) . This "mechanical" theory, perhaps the most popular explanation of ALT's mechanism of action, has been both mathematically (geometrically) and intuitively discussed in detail (Fig. 2) .'"7*'6y Histopathological examination of laser-treated meshwork samples obtained from human subjects revealed early necrosis of cells and disruption of trabecular beams. There was no evidence of penetrating holes into Schlemm's canal.'0'.'6" However, there was shrinkage of certain collagenous elements seen in some specimens.
Since there is no animal model for primary openangle glaucoma or ALT, it is difficult to confirm the mechanical theory in the laboratory. However, it is interesting to note the studies of laser-treated monkey trabecular meshwork by Melamed et al.74 These investigators noted widened intertrabecular spaces with juxtacanalicular tissue herniated into Schlemm's canal when the specimens were examined histologically. In a later study by this group, cationized ferritin was infused into the eyes of previously lasertreated cynomolgus monkeys. Light microscopy revealed that this compound, which may have acted as a tracer, had selectively shifted around the lasered areas and was noted in large quantities in the juxtacanalicular tissues, in vacuoles, and within Schlemm's canal.7' These results must be interpreted with caution, because the distribution of cationized ferritin may be charge-dependent and not simply flow-dependent.
Furthermore, this study was performed on a nonhuman, nonglaucomatous model and cannot be directly extrapolated to a proposed mechanism of action in humans. Another theory of the mechanism by which ALT lowers IOP centers on the possibility of laser-induced physiologic changes in the trabecular cells. Van Buskirk et al first reported differences in glycosaminoglycan turnover, cell density, and cellular biosynthesis measured by ""S-sulfate incorporation in laser-treated autopsy eyes.'"" Melamed et al also reported that laser-treated meshwork cells appeared to be more actively phagocytic and suggested that a cellular change had been promoted in the meshwork."
Recently, increased trabecular cell division following ALT has been demonstrated using tritiated thymidine uptake in a human organ culture system. "." Cell division at sites distant to the laser burns and migration of cells into the burn areas were documented histopathologically. (1807 with 50 burns resulted in pressure reduction comparable to that achieved with treatment of the full angle (360") with 100 burns, while causing much less acute posttreatment IOP elevation. 155 In another study of various types of glaucoma patients, 62% of patients treated over only 180" of angle were adequately controlled without requiring the second 180" to be treated.53 Other reports also reported no significant differences between groups receiving full circumference and half-circumference treatment in a prospective study.45*6g Of interest in this one report, however, was the observation that eyes with the largest pressure decreases (greater than 12 mm Hg) were most numerous in the 360" treatment group. Elsas, in contrast, in a nonconcurrent comparative study reported a higher degree of successful IOP control with 100 spots than with 50 spots.74 Other investigators who have also corroborated the clinical efhcacy of 180" treatment include Fazio et alz6 and Eguchi et al. " Wilensky and Weinreb have suggested, however, that full treatment was more likely to result in persistent pressure reductions.15'
B. LOCATION OF BURNS
The optimal location for placement of the laser burns has been addressed in several studies. Popular sites of burn placement include just along the anterior border of the pigmented meshwork and more posteriorly, directly on the pigmented meshwork, but some have treated as far posteriorly as the scleral spur." Schwartz et al studied several groups of patients having laser treatment to either posterior or anterior meshwork. They reported adequate pressure reduction regardless of treatment site."" Higgins similarly found the best response when either the posterior or anterior aspects of the meshwork were treated, although a good response was noted in all locations.4g In contradistinction, Eguchi et al noted much less success with treatment over the anterior part of the trabecular band." Most recently, Rouhiainen et al, reported that burn location did not affect outcome to any significant extent."' An associated question is whether a laser surgeon can accurately place burns on specific angle structures. Starita et a113' correlated clinical impression at the time ofALT with histopathological analysis of tissue specimens obtained at surgery. They reported that accurate placement of the laser spots was attained in 11 of 13 patients.13' (The relationship of burn placement to particular complications will be ogy, 30th Anniversary Edition, Volume I, courtesy of JB Wise, B.F. Boyd, and S. Gordon.) discussed in Section VII.)
C. ENERGY DENSITY
Energy is determined by a combination of duration, power, and spot size. Blondeau et al studied the possibility that increasing duration of the laser burn, while individually adjusting the power setting, might favorably affect response.' Their result revealed no statistically significant difference in the pressure drop following burns of either 0.1 or 0.2 set duration. Most clinicians presently utilize the 0.1 sec. spot duration, as initially described by Wise."' As previously noted, histopathological work by Starita et al suggested direct correlations among the amount of power administered, degree of pigmentation present, and the histological changes obtained."" Since power level was shown to be a relevant and controllable variable, there was a question as to what power setting was required to obtain an optimal IOP response from ALT. Rouhiainen and Terasvirta were able to demonstrate a relationship between laser power, total energy delivered, and response obtained. Those eyes receiving laser power equal to or above 500mW responded with an IOP reduction; thus the minimum power level re- The goal is to adjust the viewing pieces so that they focus at the same location (on the trabeculum) as the laser beam 50~ focal point, as shown in Fig. 3 The other group of studies with Nd:YAG lasers attempted to perform conventional laser trabeculoplasty using 10 msec pulses of neodymium laser energy. "1,"2 Treatment results were reported to be comparable to those achieved with argon energy.
IV. Results
In discussing treatment results, the success rate can be defined in many ways -e.g., 1) a pressure drop of greater than a certain percent; 2) final pressure of less than a certain level with or without medications; or 3) absence of glaucomatous disc and field progression.
In With these questions in mind, the reader should be able to carefully analyze any data and reach his or her own conclusions as to how ALT might provide longterm impact in clinical practice.
In 19X 1, Wise published the results of longterm follow-up after ALT in 150 eyes."'" All were followed for at least six months after treatment, and some had been followed for up to four years. In what is probably the longest reported followup to date, Wise recently reported the first ten-yea] results in his series."" In this report, the proportion of eyes maintaining an IOP of less than 2 1 mm Hg was 79% at one year, 63% at four years, and only 45% (76 eyes) at seven years. Interestingly, this increased to 70% at ten years in a smaller group (10 eyes). Wise suggested that the lessened effect at year seven was due to patient selection factors that were as yet undefined.
In the 37 treated eyes of'24 patients who later died, only one eye had required filtration surgery during the patient's lifetime. Thus, ALT did avoid the morbidity of conventional surgery in this group of individuals.
The "surgical rate" as a whole was reported as 92% at one year and 63% at seven years. Of prognostic significance, Wise found that those eyes having the most severe disease (cup to disc ratio > 0.9) had a 5 1% rate of undergoing surgery as opposed to those with less severe damage (cup to disc ratio ~0.9) who had a 16% glaucoma surgery rate. Overall, 30% of 1 10 eyes followed to year six required surgery despite previous ALT.
Again, Wise found that a small number of eyes of non-white patients did not appear to fare any worse than the entire group of patients.
Since a large number of patients were able to avoid glaucoma surgery throughout their lifetimes. Wise concluded that ALI' did indeed do more than merely delay surgery.
However, the results of this longterm study do suggest a loss of effect with time.
In the only tongterm report following "low dose" ALT, Barnes and Wilensky reported that I 1 of 16 eyes that had received 25 to 50 burns over 90" of the angle, demonstrated a significant and persistent IOP drop." Follow-up ranged from 1 to 4.2 years and did not include two eyes that demonstrated an average pressure rise of 2 mm Hg. This report must be interpreted with the understanding that life-table analysis was not performed and that some patients did not return for follow-up. The results indicate, however, that low dose treatment can be a viable longterm option in some patients.
Another measure of the longterm efficacy of ALT has been described by Gilbert et al."" These authors examined the rate of filtration surgery in a residency program immediately following the introduction of ALT in the clinic and several years later. In the pre-laser period from 1978 through 1981, filtration surgeries were performed, compared to only one in 1982 and 18 in 1984, most of which were done in patients who had previous ALT.
In summary, it appears that ALT is not a cure or permanent success in all patients. ALT does, however, appear to control IOP for extended periods of time in many patients and in some may eliminate the need for filtering surgery, with its attendant risks and potential complications.
B. PERIMETRY
Several investigators have studied the effect of ALT on visual field test results. Holmin and Krakau reported that successful laser trabeculoplasty failed to halt progressive visual field loss over a one-year period in 15 patients."" Heijl and Bengtsson could not demonstrate any correlation between pressure reduction and computerized field improvement in 42 eyes tested both before and one month after ALT.l" Similarly, Holmin and Bauer studied 23 eyes and were unable to demonstrate any improvement in the visual field.5' In a study of 19 patients, Schultz et al examined visual fields obtained at intervals of 1, 4, 8, and 12 months following ALT. They utilized one-way analysis of variance and trend analysis, finding that six patients showed visual field improvements, eight showed no change, and five showed progressive worsening (Octopus program 32)."" Six of their original 25 patients were excluded because of glaucoma progression that necessitated surgery or changes in medication. Lieberman et al found a worsening of visual fields in 11% of eyes with chronic open angle glaucoma (6/53) despite IOP reduction following ALT. The authors attributed this finding to a continuation of the damage in these already diseased eyes."" In contrast, Spaeth, using intricate analyses of patients who had Octopus perimetry three months and one year following ALT, found a direct correlation between intraocular pressure reduction and visual field improvement."' Traverso et al also reported some improvement in Octopus fields following ALT-induced pressure reduction.'4'4
V. Patient Factors
Ophthalmologists have observed that ALT may be more successful in some individuals than others. There are several patient factors that may be of importance in predicting a successful outcome in any particular laser candidate.
A. AGE
Over the years, a general impression has developed that younger patients have less of a response to ALT than their older counterparts.
Safran et al conducted a retrospective study comparing patients younger than and older than 40 years who had POAG uncontrolled by maximally tolerated medical treatment (range, 14-37 years; 46-85 years). lo9 Only 7% of eyes in the older group required surgical intervention after laser compared to 60% in the younger individuals. In addition, the older patients appeared to have a statistically greater decrease in pressure (12 + 6 mm Hg) in response to ALT than those less than 40 years old (5 * 6 mm Hg). The diagnosis of POAG in a younger population is complicated by the possibility that some or all of these individuals may actually represent a juvenile variant of POAG, having a prognosis and natural disease history different than the typical POAG seen in older patients. Regardless, the poorer response to ALT in younger patients has also been reported by others and should be borne in mind when counselling the younger laser candidate."0,4',l"6
B. RACE
There are a number of reasons why black patients would be ideal candidates for ALT. One of the most salient concerns is the significantly lower success rate following filtering surgery in this group than in white patients. 'lo As such, avoidance of conventional surgery would be most desirable. Following ALT in a predominantly black group of patients, Schwartz et al reported a 97% success rate with an 18-month follow-up."" Krupin et al, retrospectively examined the results of ALT in 68 black and 42 white POAG patients over one-and two-year periods (only 13 patients had not returned for followup at two years), found no statistical difference in the response seen between black and white patients.64 Similar results have also been reported in other studies,"'and ALT in an Asian population has also provided equivalent responses and success rate. '25 With longer follow-up of previously studied individuals, however, Schwartz et al found that
ALT did fail to a greater degree in black patients than in whites."" In light of these conflicting findings, further studies are necessary to settle this controversy. Although not absolute, this figure can serve as a guide in predicting the maximal response that could be reasonabl) expected in a given patient."",'""
E. RESULTS IN THE FELLOW EYE
Primary open-angle glaucoma is usually a bilateral disease, although there may be some asymmetry between the two eyes as to the time of presentation and the severity of the disease. Exfoliation and pigmentary glaucomas are bilateral in the majority of patients. Therefore, it is not unusual to have a patient who has already had ALT in one eye and presents with medically uncontrolled IOP in the second eye. Does the result in the first eye indicate what will happen in the second eye? In one of the early reports on ALT, the authors state that there was an asymmetric response between eyes in 9 of 19 patients, but did not provide detailsfi' Two later larger studies in which statistical analysis was performed found a significant correlation between the response in the two eyes. In one of these studies the correlation was still present three years after treatment,"."'~ These later studies are more in keeping with our own results. In general, if a good response has occurred in the first eye, the second eye will also do well. Conversely if we have not obtained much response in the first eye, it is uncommon for us to see a good response in the second eye.
F. STAGE OF GLAUCOMA Some observers believe that ALl' is more successful in early glaucoma than in more advanced disease. Wise states that 51% of eyes with a cup/disc ratio of 0.9 or more required surgery subsequent to ALT as compared to only 15% of eyes with smaller cup/disc ratios. 17" On the other hand he states that the prelaser average pressure and pressure drop from ALT were similar in the two groups. Thus, he is probably indicating that eyes with more advanced glaucomatous damage require a lower IOP to halt progression of disease, and not that ALT has a lesser IOP lowering effect in these eyes. Tuulonen et al studied factors influencing the outcome of laser trabeculoplasty.
They reported that severity of the glaucoma alone would have been a significant predictor, but its importance was lost when the indication for treatment was included."'","I'hey also found that previous use of pilocarpine was a negative predictive factor. transplant patients during a mean follow-up period of 12 to 37 months.
VI. Diagnosis-related Effkacy of Treatment

K. MISCELLANEOUS
ALT has been performed in a wide variety of other glaucomas, such as congenital glaucoma, iridocorneal endothelial syndrome, and Sturge-Weber; however, not enough subjects with follow-up are available to determine whether ALT is a viable alternative in these and other secondary glaucomas 65,97,12X
VII. Complications
As with all therapeutic interventions, benefits must be weighed against potential risks. ALT has been associated with several adverse effects, ranging from minor to catastrophic (Table 1) . Together, physician and patient must be aware of these possible complications before proceeding with laser therapy. 
A. PRESSURE ELEVATION
E. HYPHEMA
Transient microhyphemae were found in 2.3% of treated patients in the study by Thomas et al."" Earlier, Wise had reported a similar incidence of 57~.'~'" These small hyphemae can usually be controlled by direct photocoagulation, as described by Wise"'",'"" and Thomas et a1,1s4 and are of minor significance.
F. CORNEAL SEQUELAE
Cornea1 burns of both the epithelium and deeper layers have been seen and described by several authors, but these were in the early studies and have not been reported recently.x",'""."'" Hong et al reported significant increases in cell size following laser trabeculoplasty in 10 eyes at 6 and 12 months of follow-up."" In other prospective studies, however, no real effect on endothelial morphology, cell density, """' or functionlg could be found. Although transient worsening of cornea1 edema in a patient with Fuchs' dystrophy Ifi" and late-onset bullous keratopathy in a traumatized eye'"" have been reported, we do not believe that permanent or significant cornea1 damage is a likely complication. Perhaps more significant is that cornea1 pathology may adversely affect the view of the angle structures, making treatment more difficult and at times impossible.
G. SYNCOPE
As with any procedure that involves pressure on the globe or ocular manipulation in anxious patients, syncope should be anticipated.
Hoskins et al reported four such patients, three of whom were less than 40 years old.;'" It is unclear whether the laser aspects of the procedure might actually play a role in this adverse reaction.
H. EFFECT ON FUTURE FILTRATION SURGERY
In recent years, there have been thoughts expressed in the literature that ALT may lessen the chances of success of conventional filtration surgery,GVl.!'.' In a series of 438 trabeculectomies on 435 eyes of 344 patients, Gross et al reported an overall 281(' incidence of encapsulated blebs, increasing from 26% in 1983 to 33% in 1986. Patients with previous ALT demonstrated a doubling in the incidence of encapsulated blebs compared to those without it (33%' versus 16%)."" Perkins et alx" and Richter et al!"' have also expressed the concern that AL'l' may in some way be related to the increased rate of encapsulated blebs seen in recent years. In the study by Richter and associates, encapsulation of the bleb was found to have occurred in 56 of 409 consecutive filtering procedures during a 40-month period. This complication occurred in 42 of 272 (15.4%) eyes that had received previous ALT compared to only 4 of 85 non-laser-treated eyes (4.7%). Neither the interval between laser and filtration surgery nor the number of spots were statistically linked to the risk of encapsulation in these subjects.
The Advanced Glaucoma Intervention Study, which will be described in Section IX, may provide definitive information regarding this association. Until that time, however, we would discourage the routine use of ALT in every presurgical patient unless a reasonable chance of success exists. It is worthwhile noting, however, that ALT avoids much of the acute morbidity usually associated with conventional filtration procedures. Post-treatment discomfort, medical care, and requirements for follow-up are usually less of a problem with this technique. Risks of expulsive choroidal detachments, endophthalmitis, and anesthetic reactions are avoided.
ALT also has the distinct advantage of avoiding progressive cataract formation, which is often seen in the years following conventional filtration surgery."'
VIII. Retreatment
Unfortunately, most clinicians have seen a return to unacceptable intraocular pressure levels in some of their patients who initially had been controlled following ALT. Since filtration surgery is usually the next option, several investigators have been motivated to try retreatment with AL?' in selected cases. Starita et al retreated 17 eyes that had been classified as failures after initial full ALT.""' In 35% of eyes, a reduction in IOP of greater than 3 mm Hg along with stabilization of visual fields was obtained (average follow-up, 12 weeks). Three of the patients (18%) experienced an acute rise in IOP 2 10 mm Hg within four hours of treatment and one additional patient had a similar elevation at one week. Brown and associates retreated 26 eyes with both primary and secondary glaucomas that had shown pressure reduction following previous initial ALT treatment (360" in one session or 180' in two sessions), on average, 16 months earlier." Following the retreatment, which was divided into two sessions of 180" in most subjects, ten eyes (38.5%) had pressure elevation averaging 9.9 mm Hg and three of these had increased pressure ranging from 10 to 37 mm Hg. Eight of these retreatment failures demonstrated progressive visual field deterioration and required surgery within one month. Fourteen eyes (54%) did respond with a pressure reduction averaging IO.4 mm Hg. These eyes had stable visual fields and were considered retreatment successes at an average follow-up of five months.
Richter and coworkers retreated 180" of angle in 40 eyes that had undergone previously successful ALT with 360" of treatmentgY Retreatment success, described as an IOP decrease of 3 mm Hg or more, stable optic disc and visual fields, and avoidance of conventional surgery was achieved in only 32% of all eyes. Furthermore, Kaplan-Meier survival analysis predicted a progressively lower likelihood of maintained success, particularly after one year. Unlike in the study by Brown et al," who treated the full circumference, no patients experienced IOP elevation greater than 6 mm Hg in the immediate post-laser period and none required urgent filtration surgery as a result of the technique.
Recently, Grayson et al reported on their experience with retreatment of 38 eyes, most of which were phakic and had POAG."' Retreatment was performed an average of two years following the initial treatment, which was at first successful. They reported a successful outcome in 73% of eyes at 12 months following retreatment. However, of those 15 eyes that underwent a second retreatment at 6 to 47 months after the first retreatment, eight (53%) required conventional filtration surgery.
It is important to recognize that the initial ALT treatment consisted of fewer burns (mean = 65) than are usually applied by most clinicians.
Similarly, Weber et al retreated 37 eyes classified as late treatment failure with an additional 50 laser spots scattered over 360".15" The IOP decreased by an average 6.4 mm Hg one month after the retreatment and all eyes were considered to have had a successful response at one month. The success rate had dropped to 70% by one year, and to 47% at 16 months. In a smaller series, Messner et al found retreatment successful in only a small percentage of their patients. They have raised the point that ALT retreatment may serve to delay necessary filtering surgery in the majority of cases.76
As can be seen, experience with retreatment has been variable and only a minority of patients have been able to avoid progression of disease for more than an additional year or two. AI1 patients should be aware of the lower success rate, and the possibility of acute and chronic pressure elevation that have been described with retreatment. We tend to limit the use of retreatment to very elderly or infirm patients who experienced a good response to ALT that had been performed at least several years earlier. The two year follow-up results of the GLT Study have recently been published.
IX. Ongoing Studies
A. ALT AS A PRIMARY TREATMENT
In the eyes that were treated with ALT as the initial treatment, 44% remained under control after two years of follow-up with the laser treatment alone, and 70% remained under control with either the laser alone or a combination of the laser treatment and timolol. If another single topical antiglaucoma drop (pilocarpine or dipivefrin) was substituted for the timolol, then a total of 84% of eyes were controlled by laser alone or laser plus one antiglaucoma medication.
Of eyes begun on medical treatment, 30% had the intraocu-lar pressure controlled at the end of two years with timolol alone. If another single antiglaucoma topical medication (again, pilocarpine or dipivefrin) was substituted for the timolol, then an additional 2 1%~ were controlled, and, thus, a total of 5 1% of the medically treated eyes were controlled by a single agent. With any combination of one or two antiglaucoma drops, a total of 66% of eyes were under control at the end of two years.
Looking at the same data in the opposite way, 16%' of the eyes were not controlled at the end of two years by laser alone or a combination of laser and one antiglaucoma medication, while 34% of the medically treated eyes were not controlled by one or an)' combination of two antiglaucoma medications at the end of two years. Also, the average intraocular pressure in the eyes that were treated first with ALT was approximately 2 mm Hg lower than the average intraocular pressure in the eyes that are treated with medicines alone. There was no significant difference at the end of two years in the visual field between the eyes treated first with the laser 01 with medication.
Among the arguments for beginning with laser treatment are that patients will be spared the exposure to the potential of serious side effects and complications of medical therapy and that patient compliance is eliminated as a factor in control of tht glaucoma.
Since more than half the patients in the GLT Studys56ended up on medical therapy by the end of two years of follow-up, then those potential advantages were of only transient benefit to those patients. On the other hand, there clearly may be a convenience factor for the patient to use only one drug rather than the two, and the average IOP in the eyes treated with the laser was lower than that of the eves treated with medicine alone. Therefore, a reascinable case can be made to justify using ALT as the first avenue of treatment of primary open angle glaucoma.
Whether these advantages are sufficient to justify this break with traditional practice and whether just two years of follow-up is adequate to make such a decision is something that each practitioner will have to decide individually.
to 10% of the trabeculectomy group. A similar but much larger prospective study is the multicenter National Eye Institute sponsored Advanced Glaucoma Intervention Study (AGIS). Individuals will be randomized into one of two treatment pathways: 1) ALT followed by trabeculectomy if necessary, followed by repeated trabeculectomy as needed; or 2) trabeculectomy followed by AL?', if needed, followed by repeated trabeculectomy as needed.
It is hoped that this study will not only provide indications for the use of ALT versus filtering surgery, but will also indicate whether ALT itself has any effect on the success of subsequent filtering surgery.
X. Recommendations for Treatment
A. TREATMENT PARAMETERS
Since many patients achieve a significant (and sometimes minimal) IOP reduction with treatment of only 1X0", which reduces the risk of post-treatment elevated IOP, we recommend performing laser trabeculoplasty in two sessions. In rare instances when there is very advanced glaucomatous damage, we may deliver the treatment in 90" increments. Usually the second treatment will be performed one month after the initial one, but occasionally when the IOP reduction has exceeded our treatment objective, we may defer the second treatment session. We recommend placing the treatment burns at the junction of the anterior border of the pigmented and nonpigmented trabecular meshwork. This seems to result in less pain during treatment, fewer peripheral anterior synechiae. and less postoperative inflammation.
We use a 50~ spot fix 0.1 seconds. We differ among ourselves as to laser power. One of us uses a standard power setting (XOOmW) for all treatments while the other two vary the power between 500 and 1000mW. depending on the tissue reaction.
We all use blue-green argon lasel energy for the treatment. Another factor that must be considered is the age of the patient.
B. PATIENT MANAGEMENT AT THE TIME OF TREATMENT B. ALT VERSUS FILTERING SURGERY
As has been pointed out, younger patients do not tend to respond as well to ALT. Also, because of their longer life expectancy, younger patients need their IOP reduction to be sustained for a longer time. As has been demonstrated, the ALTinduced IOP reduction does not appear to be permanent in most cases. Therefore, in general, the younger the patient, the less likely we are to recommend ALT. Conversely, the older and more infirm the patient, the more likely we are to use it.
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